Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

93
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
93
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

871
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
871
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

14
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Antimicrobial Proteins01:23

Antimicrobial Proteins

4.2K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
4.2K
Antidotes01:17

Antidotes

752
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
752
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ligand-mediated formation of amphiphilic silver nanoclusters: synthesis, redox properties, and activity against clinically relevant bacteria.

Journal of materials chemistry. B·2026
Same author

Electrochemical Detection of Levofloxacin Using a Polydopamine-Based Molecular Imprinting Polymer.

Molecules (Basel, Switzerland)·2026
Same author

Comprehensive Speciation and Computational Study of Cu<sup>2+</sup> and Zn<sup>2+</sup> Complexation with O-Phosphorylethanolamine and O-Phosphorylcholine in Aqueous Solution.

Molecules (Basel, Switzerland)·2025
Same author

Speciation and Thermodynamic Study of Arsenic(III)-Pharmaceutical Complexes in Aqueous Solutions.

ACS environmental Au·2025
Same author

Engineered carbon electrode with graphene-cyclodextrin/ferrocenyl-carnosine nanoassembly for Mn(ii) detection.

RSC advances·2025
Same author

Metal Complexation for the Rational Design of Gemcitabine Formulations in Cancer Therapy.

ACS applied materials & interfaces·2024

Related Experiment Video

Updated: Sep 3, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K

Metal-Based Compounds in Antiviral Therapy.

Chiara Abate1, Federica Carnamucio1, Ottavia Giuffrè1

  • 1Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.

Biomolecules
|July 27, 2022
PubMed
Summary

Metal complexes and nanomaterials show promise as antiviral agents. Gold and silver nanoparticles offer enhanced antiviral activity and improved drug delivery, leading to safer therapies with fewer side effects.

Keywords:
antiviral drugsdrug deliverymetal compoundsmetal nanoparticlesvaccines

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Related Experiment Videos

Last Updated: Sep 3, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Area of Science:

  • Inorganic Chemistry
  • Nanotechnology
  • Pharmacology

Background:

  • Metal complexes and metal-based nanomaterials are gaining attention for their potential in treating viral diseases.
  • Research is exploring their chemical properties for enhanced antiviral efficacy.

Purpose of the Study:

  • To review the use of metal-based nanoparticles as antiviral drugs.
  • To analyze how metal-nanoparticle interactions enhance antiviral activity.
  • To discuss their application in vaccine formulation and drug delivery systems.

Main Methods:

  • Literature review focusing on chemical properties of metal complexes and nanoparticles.
  • Analysis of studies on metal-based nanoparticles for antiviral applications.
  • Examination of nanoparticle characteristics relevant to drug delivery and adjuvant activity.

Main Results:

  • Metal-based nanoparticles demonstrate substantial enhancement in antiviral activity.
  • Certain metal complexes exhibit remarkable adjuvant activities, beneficial for vaccine formulation.
  • Gold (Au) and silver (Ag) nanoparticles, due to their size and inertness, are suitable for targeted antiviral drug delivery.

Conclusions:

  • Metal-based nanomaterials represent a promising avenue for developing effective antiviral therapies.
  • Nanoparticle-based drug delivery systems can lead to more specific and safer treatments with reduced side effects.
  • Further research into metal complexes and nanoparticles can advance antiviral strategies and vaccine development.